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Abstract:  Fluorescence enhancement of fluorescein isothiocyanate-labeled protein A 
(FITC-protein A) caused by the binding with immunoglobulin G (IgG) in bovine plasma 
was studied. FITC-protein A was immobilized onto a glass surface by covalent bonds. An 
increase in fluorescence intensity was dependent on IgG concentration ranging from 20 to 
78 g/mL in both phosphate buffer saline and bovine plasma. This method requires no 
separation procedure, and the reaction time is less than 15 min. A fluorescence 
enhancement assay by the affinity binding of fluorescence-labeled reagent is thus available 
for the rapid determination of biomolecules in plasma. 
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1. Introduction 
 
Fluorescence measurement has been widely used in immunoassay and in determination of   
bio-interactions. Determination of fluorescence properties enables analysis of micro-environmental 
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changes near fluorescence dyes and biomolecular interactions [1-3]. Progress in optical devices 
provides a convenient and portable measuring system using a diode laser as light source and a charge-
coupled device (CCD) as fluorescence detector [4]. These improvements make it possible to apply 
fluorescence assays to on-site and rapid measuring systems. 
Some authors have reported the measurement of biomolecules and biologically active compounds 
by fluorescent enhancement [5-7]. This method is based on the enhanced fluorescence intensity of a 
fluorescent-labeled reagent which interacts with a target substance. The affinity binding of the target 
substance with the labeled reagent provides a hydrophobic microenvironment near the fluorescence 
label, which results in the enhancement of fluorescence. The determination of biomolecules by 
fluorescence enhancement has advantages of convenience and speed. 
In the application of fluorescence enhancement in immunoassay, the time of determination is 
shortened to less than 5 min because of the separation-free and reagent-less method [8]. Also this 
simple method is independent of operator skill, so its application to in situ measurements, like 
preliminary diagnostics or environmental measurements, is expected. For these purposes, less 
pretreatment of sample solutions is required.  
The objective of the present study is to evaluate fluorescent enhancement of a fluorescein 
isothiocyanate-labeled protein A by the affinity binding with immunoglobulin G in bovine plasma. 
Application of this fluorescence enhancement immunoassay for plasma samples is discussed in 
comparison with the fluorescence in buffer solution. 
 
2. Experimental Section  
 
2.1. Materials 
 
Chemicals were purchased from Wako Pure Chemicals Industry (Osaka, Japan) unless otherwise 
mentioned. Toluene was used after dehydration with molecular sieves (4 Å). Bovine plasma was 
obtained by centrifugation from bovine blood containing anticoagulant (hematocrit: 30.0%–38.4%, 
total protein: 8.13–9.08 g/dL, anticoagulant: 10 vol% of 3.2 w/v% sodium citrate). Stock solution of 
immunoglobulin G (IgG) was prepared by diluting rabbit IgG purchased from Nordic Immunological 
Laboratories (Tilburg, Netherlands). Sample IgG from rabbit is known to bind with protein A strongly. 
Bovine plasma was selected as bulk solvent for the ease of use and weak binding ability of bovine IgG 
to protein A. Fluorescein isothiocyanate (FITC) was used for the fluorescence label because the 
fluorescence enhancement of FITC caused by micro-environmental change has been well established 
by many authors [7-9]. Other regents were used without further purification. 
 
2.2. Immobilization of FITC-labeled protein A 
 
A glass slide (8 mm × 8 mm) was reacted with 3.8 vol% 3-aminopropyltrimethoxysilane (Tokyo 
Chemical Industry, Tokyo, Japan) in dehydrated toluene at 383 K for 6 hr. The silanized glass was 
immersed in 1% glutaraldehyde solution for 1 hr. FITC-labeled protein A (FITC-protein A; Zymed 
Laboratories, South San Francisco, CA, USA) was immobilized onto the glass by immersing the glass 
in a phosphate buffer saline (PBS, pH 7.4) containing 25 g/mL FITC-protein A for 40 hr. The Sensors 2009, 9                                       
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procedure for immobilization of FITC-protein A is shown in Scheme 1. After FITC-protein A was 
immobilized, the glass slides were treated in dark. The FITC-protein A immobilized glass was 
immersed in 0.5 g/L bovine serum albumin (BSA) solution for 1 hr to block nonspecific adsorption. 
The glass was stored in PBS at 277 K.  
Scheme 1. Procedure for immobilization of FITC-labeled protein A. 
 
 
2.3. Fluorescence intensity measurement 
 
The glass slide was located in a plastic cell containing 2 mL buffer or 2 mL bovine plasma solution 
as shown in Figure 1. IgG concentration of sample solution was adjusted by adding 10–40 L of  
4 mg/mL IgG stock solution to sample solvent in the cell. Fluorescence intensity was measured at an 
excitation wavelength of 498 nm on spectrofluorophotometer (RF-5300PC, Shimadzu, Kyoto, Japan). 
The excitation light was irradiated at an incident angle of over 45º to glass surface, and emission light 
was collected near a perpendicular line to separate emission light from reflection light. The average 
value for fluorescence intensities from 519 nm to 521 nm at steady state was used for analysis of IgG 
concentration dependency, whereas the integration of the intensity was used in previous report [8]. 
Experiments of fluorescence intensity were performed at 310 K under stirring. 
Figure 1. Experimental setup for measurement of fluorescence intensity. 
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3. Results and Discussion 
 
3.1. Fluorescence spectrum of FITC-protein A immobilized glass 
 
Fluorescence spectra of FITC-protein A immobilized glass in bovine plasma are shown in Figure 2. 
Without the glass, broad band emission of bovine plasma was observed (line a in Figure 2). This 
fluorescence is emitted in the presence of plasma protein and bilirubin [10]. After setting the   
FITC-protein A immobilized glass in the plastic cell, a maximum fluorescence intensity was observed  
at 520 nm (line b in Figure 2). The maximum fluorescence intensity with FITC in PBS at 520 nm 
indicates that the FITC-protein A is immobilized on the glass [8]. By addition of IgG up to 78 g/mL, 
FITC emission at 520 nm was enhanced (line c in Figure 2). Since a steady state of fluorescence 
intensity was reached at 15 min after addition of IgG solution, IgG measurements were performed  
after 15 min.  
To determine whether the fluorescence enhancement was caused by the native plasma protein or 
immobilized FITC-protein A, fluorescence spectrum of plasma solution without FITC-protein A 
immobilized glass was measured. Fluorescence spectrum was unchanged by adding IgG in the absence 
of FITC-protein A glass. Fluorescence enhancement shown in Figure 2 results from immobilized   
FITC-protein A. 
Figure 2. Fluorescence spectrum of immobilized FITC-Protein A. Line 'a' is spectrum of 
bovine plasma without FITC-Protein A immobilized glass, Line 'b' is spectrum of 
immobilized FITC-Protein A immersed in bovine plasma, Line 'c' is enhanced fluorescence 
spectrum at 78 g/mL IgG in bovine plasma.  
 
 
3.2. Dependency of fluorescence enhancement on IgG concentration 
 
Differences in the amount of immobilized FITC-protein A and in the FITC/protein A molar ratio 
cause various fluorescence intensities of immobilized FITC-protein A for the test glasses. To correct 
the individual variability, relative fluorescence intensity, ratio of fluorescence intensity after IgG 
addition to that before IgG addition, was used. Dependence of relative fluorescence intensity on IgG Sensors 2009, 9                                       
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concentration is shown in Figure 3. Relative fluorescence intensity increased with IgG concentration, 
and reached approximately 1.3 at 78 g/mL IgG in bovine plasma. Relative fluorescence intensity 
gave a good correlation between PBS and bovine plasma. IgG in bovine plasma is hence measurable 
by fluorescence enhancement of immobilized FITC-protein A. 
Figure 3. Dependency of relative fluorescence intensity on IgG concentration. Black 
circles denote FITC-protein A immobilized glass in bovine plasma, White circles denote  
FITC-protein A immobilized glass in PBS, Gray triangles denote plasma solution without 
glass for blank test. 
 
 
It has been reported that the degree of fluorescence enhancement of FITC caused by affinity 
binding  was 1.6-fold with protein A ― IgG interaction in PBS [8] and 1.5-fold with DNA interaction 
[7]. On the other hand, glycerin treatment enhances fluorescence of immobilized FITC-labeled 
antibody by approximately 1.5-fold [9]. The lower fluorescence enhancement shown in Figure 3, 
which may be caused by differences in purification or preservation of the purchased reagents, leaves 
much room for fluorescence enhancement at higher IgG concentrations.  
There are some reasons accounting for fluorescence enhancement of fluorescent label, such as the 
microenvironment of fluorescence dye, viscosity and polarity of solvent [11-13]. Fluorescence 
enhancement caused by affinity binding may result from the hydrophobic microenvironment [7,8]. The 
fluorescence enhancement of FITC-protein A after binding with IgG in bovine plasma gave almost the 
same relative fluorescence intensity as that in PBS, demonstrating relatively low difference in solvent 
effect on fluorescence enhancement between buffer solution and plasma.  
According to the Student's t-test, there was a significant difference in relative fluorescence intensity 
between 0 and 20 g/mL IgG in bovine plasma (P < 0.05, Figure 3). Hence IgG is detectable by the 
fluorescence enhancement at over 20 g/mL IgG in bovine plasma. However no significant difference 
was observed between plasma measurement and blank test at 20 g/mL IgG (P > 0.05). It seems to be 
caused by the dispersion of FITC-Protein A-immobilization in each sample glass and plasma-related 
noise for fluorescence. More sensitive measurement will be achieved by the further improvement in 
immobilization method and choice of fluorescence dye, because fluorescence wavelength of FITC is 
overlapped with that of plasma.  Sensors 2009, 9                                       
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Application of the fluorescence enhancement method in the determination of edaravone [6] and 
dioxins [7] has been reported. This method has a potential applicability to measure substrates which 
interact with other molecules. Most expected applications are to determine antigens using   
labeled-antibodies and also antibodies using labeled-antigens. Fluorescence enhancement after an 
antigen-antibody reaction depends on the molecular weight and hydrophobicity of the antigen and also 
a method of labeling antigen and antibody. 
Because measurement of fluorescence enhancement using the fluorescence reagent-immobilized 
glass is a reagent-less and non-separation method, it has advantages for real time and on-site 
measurements. This method is applicable to the case of bovine plasma, and the measurement time is  
approximately 15  min. Such a simple and convenient assay is  useful for in situ and   
diagnostic measurements. 
 
4. Conclusions  
 
Fluorescence of FITC-protein A in bovine plasma increases with IgG concentration. Extent of 
fluorescence enhancement in bovine plasma is almost the same as that in PBS. We are able to 
determine IgG in bovine plasma at 20–78 g/mL within a reaction time of 15 min. The fluorescence 
enhancement assay is available for convenient and rapid determination of biomolecules in plasma. 
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